Skip to main navigation
Skip to search
Skip to main content
OSU Center for Health Sciences Research Profiles Home
Help & Contact
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Molecular interaction of bupropion with nicotinic acetylcholine receptors
Hugo R. Arias
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Molecular interaction of bupropion with nicotinic acetylcholine receptors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Nicotinic Acetylcholine Receptor (nAChR)
100%
Bupropion
100%
Molecular Interactions
100%
Acetylcholine Receptor (AChR)
66%
Inhibitory Action
22%
Ion Channels
22%
Dopamine
11%
Mechanism of Action
11%
Neurotransmitters
11%
Nicotine
11%
Desensitization
11%
Dopamine System
11%
Ventral Tegmental Area
11%
Cellular Level
11%
Selective Serotonin Reuptake Inhibitors
11%
Competitive Antagonist
11%
Pharmacological Mechanism
11%
Reuptake
11%
Norepinephrine System
11%
Anti-addiction
11%
Receptor 1
11%
Tricyclic Antidepressants
11%
Phencyclidine
11%
Antidepressants
11%
Valine
11%
Clinical Activity
11%
Resting State
11%
Muscle Acetylcholine Receptor
11%
Channel Opening
11%
Ligand-binding Domain
11%
Antinicotinic
11%
New Evidence
11%
Sequential Mechanisms
11%
GABAergic Neurons
11%
Neuroscience
Nicotinic Acetylcholine Receptor
100%
Bupropion
100%
Cholinergic Receptor
77%
Norepinephrine
22%
Ion Channel
22%
Neurotransmitter
11%
Serine
11%
Ventral Tegmental Area
11%
Reuptake
11%
GABA Receptor
11%
Tricyclic Antidepressant
11%
Phencyclidine
11%
Antidepressant
11%
Selective Serotonin Reuptake Inhibitor
11%
Valine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinic Receptor
100%
Bupropion
100%
Cholinergic Receptor
77%
Noradrenalin
22%
Ion Channel
22%
Neurotransmitter
11%
Tricyclic Antidepressant
11%
Valine
11%
Antidepressant
11%
Desensitization
11%
Serine
11%
Phencyclidine
11%
4 Aminobutyric Acid Receptor
11%
Selective Serotonin Reuptake Inhibitor
11%